Boston Tech
Biogen Got an At-Home Leqembi Start Approved, and Cambridge Just Shortened the Infusion Pilgrimage
FDA approved Leqembi IQLIK's at-home starting dose on July 13, giving Cambridge-based Biogen a meaningful Alzheimer's access and workflow win.